Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Expert Analyses of the following article:

FDA Okays FluMist Vaccine For Young Children

Source: www.medicalnewstoday.com
Tim GallagherSeptember 24, 2007
FDA Approval Of FluMist For Use In Young Children Boon For MedImmune
Author: Tim Gallagher, RPh, Executive Vice President of Pharmacy Operations , Astrup Drug, Inc.
The FDA recently approved the expanded use of FluMist, the only nasal spray influenza vaccine, in children 2 to 5 years of age. Each year in the U.S up to 60 million Americans get the flu according to the CDC. The U.S. CDC recommends all children aged 6 to 59 months be vaccinated against the flu. FluMist uses a live, attenuated virus rather than an inactive virus.  A recent study indicates...
September 24, 2007
Nice to see the approved age range getting larger
Author: GLG Expert Contributor
More candidates for Flumist have thus been identified. But the cost and insurance coverage issues remain, as does the fact that it is not approved for anyone with a significant health issue.
September 24, 2007
It's About Time
Author: GLG Expert Contributor
- flumist will prove attractive to parents of young children, because   young children are the group most traumatized by injections

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-11-21T17:45:19.123